Life Science Investing Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Life Science Investing Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Life Science Investing Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
Life Science Investing Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting
Silver Dollar Discovers New Mineralized Zone at the Nora Silver-Gold Project and Receives Drill Permit
Terra Clean Closes the Acquisition of the Past Producing Uranium Claims in San Rafael Swell, Utah, United States
CHARBONE Confirms Construction Schedule on Track at Sorel-Tracy and Announces the Imminent Start of Equipment Installation Phase
